Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age

NCT00860067 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00860067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age
Lead sponsor
MedImmune LLC
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2009
Enrollment
1,800 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

healthy or stable underlying chronic medical condition